Cover Image
Market Research Report

Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

Published by IMARC Services Private Limited Product code 821327
Published Content info 96 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
Published: April 8, 2019 Content info: 96 Pages
Description

Europe specialty generics market reached a value of US$ 13.2 Billion in 2018. Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic by nature and life-threatening like hepatitis C, cancer, rheumatoid arthritis, multiple sclerosis, etc.

Driven by factors such as an increasing aging population, changing lifestyles and a rising prevalence of chronic diseases, healthcare costs in Europe have increased significantly in recent years creating a huge burden on the government, healthcare providers and patients. Specialty generics are playing a major role in the region to reduce this cost burden as they are more cost-effective as compared to their branded versions. Unlike branded speciality drugs, specialty generics don't require expensive and time-consuming research and development procedures. Additionally, they also don't incur the same amount of marketing and promotional expenses, resulting in substantially lower costs. In addition to this, the patent expiration of several blockbuster specialty drugs is expected to expire in the coming years creating a positive impact on the market. Looking forward, IMARC Group expects the market value to reach US$ 21.9 Billion by 2024, exhibiting a CAGR of around 9% during 2019-2024.

Market Scope:

Historical, Current and Future Market Trends

Market Breakup by Region:

  • Italy
  • Germany
  • France
  • United Kingdom
  • Spain
  • Rest of Europe

Market Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others

Market Breakup by Indication:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others

Market Breakup by Distribution Channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies

Competitive Landscape

The leading players in the European specialty generics industry have also been examined in the report.

Key Questions Answered in This Report:

  • How has the European specialty generics market performed so far and how will it perform in the coming years?
  • What is the breakup of the European specialty generics market based on the region?
  • What is the breakup of the European specialty generics market based on the route of administration?
  • What is the breakup of the European specialty generics market based on the indication?
  • What is the breakup of European specialty generics market based on the distribution channel?
  • What are the various stages in the value chain of the specialty generics industry?
  • What are the key driving factors and challenges in the European specialty generics market?
  • What is the structure of the European specialty generics industry and who are the key players?
  • What is the degree of competition in the European specialty generics market
Table of Contents
Product Code: SR1018F32_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

  • 4.1 What are Specialty Generic Drugs?
  • 4.2 Types of Specialty Generics

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Market Breakup by Route of Administration
  • 6.4 Market Breakup by Indication
  • 6.5 Market Breakup by Distribution Channel
  • 6.6 Market Breakup by Region
  • 6.7 Market Forecast

7 Europe Specialty Generics Market

  • 7.1 Market Overview
  • 7.2 Market Performance
  • 7.3 Market Breakup by Route of Administration
  • 7.4 Market Breakup by Indication
  • 7.5 Market Breakup by Distribution Channel
  • 7.6 Market Breakup by Region
  • 7.7 Market Forecast
  • 7.8 SWOT Analysis
    • 7.8.1 Overview
    • 7.8.2 Strengths
    • 7.8.3 Weaknesses
    • 7.8.4 Opportunities
    • 7.8.5 Threats
  • 7.9 Value Chain Analysis
  • 7.10 Porters Five Forces Analysis
    • 7.10.1 Overview
    • 7.10.2 Bargaining Power of Buyers
    • 7.10.3 Bargaining Power of Suppliers
    • 7.10.4 Degree of Competition
    • 7.10.5 Threat of New Entrants
    • 7.10.6 Threat of Substitutes
  • 7.11 Key Market Drivers and Success Factors

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.1 Market Forecast

9 Market Breakup by Indication

  • 9.1 Oncology
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Autoimmune Diseases
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Infectious Diseases
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Retail Pharmacies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Specialty Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Hospital Pharmacies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 Italy
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Germany
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 France
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 United Kingdom
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Spain
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast
  • 11.6 Rest of Europe
    • 11.6.1 Market Trends
    • 11.6.2 Market Forecast

12 Competitive Landscape

  • 12.1 Market Structure
  • 12.2 Key Players
  • 12.3 Profiles of Key Players

List of Figures

  • Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2013-2018
  • Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2018
  • Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2018
  • Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2018
  • Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2018
  • Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 7: Europe: Specialty Generics Market: Sales Value (in Billion US$), 2013-2018
  • Figure 8: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2018
  • Figure 9: Europe: Specialty Generics Market: Breakup by Indication (in %), 2018
  • Figure 10: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2018
  • Figure 11: Europe: Specialty Generics Market: Breakup by Region (in %), 2018
  • Figure 12: Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 13: Europe: Specialty Generics Industry: SWOT Analysis
  • Figure 14: Europe: Specialty Generics Industry: Porter's Five Forces Analysis
  • Figure 15: Europe: Specialty Generics Market (Administration Through Injectables): Sales Value (in Million US$), 2013 & 2018
  • Figure 16: Europe: Specialty Generics Market (Administration Through Injectables) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 17: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Million US$), 2013 & 2018
  • Figure 18: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 19: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Million US$), 2013 & 2018
  • Figure 20: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 21: Europe: Specialty Generics Market (Oncology): Sales Value (in Million US$), 2013 & 2018
  • Figure 22: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 23: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Million US$), 2013 & 2018
  • Figure 24: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 25: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Million US$), 2013 & 2018
  • Figure 26: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 27: Europe: Specialty Generics Market (Other Indications): Sales Value (in Million US$), 2013 & 2018
  • Figure 28: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 29: Europe: Specialty Generics Market: Sales Through Retail Pharmacies (in Million US$), 2013 & 2018
  • Figure 30: Europe: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Million US$), 2019-2024
  • Figure 31: Europe: Specialty Generics Market: Sales Through Specialty Pharmacies (in Million US$), 2013 & 2018
  • Figure 32: Europe: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Million US$), 2019-2024
  • Figure 33: Europe: Specialty Generics Market: Sales Through Hospital Pharmacies (in Million US$), 2013 & 2018
  • Figure 34: Europe: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Million US$), 2019-2024
  • Figure 35: Italy: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 36: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 37: Germany: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 38: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 39: France: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 40: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 41: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 42: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 43: Spain: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 44: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 45: Rest of Europe: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 46: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

  • Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
  • Table 2: Europe: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
  • Table 3: Europe: Specialty Generics Market Forecast: Breakup by Route of Administration (in Million US$), 2019-2024
  • Table 4: Europe: Specialty Generics Market Forecast: Breakup by Indication (in Million US$), 2019-2024
  • Table 5: Europe: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Million US$), 2019-2024
  • Table 6: Europe: Specialty Generics Market Forecast: Breakup by Region (in Million US$), 2019-2024
  • Table 7: Europe: Specialty Generics Market Structure
  • Table 8: Europe: Specialty Generics Market: Key Players
Back to Top